Stress and proliferation states impact microRNA-mediated regulation in cancer

应激和增殖状态影响 microRNA 介导的癌症调节

基本信息

  • 批准号:
    7848122
  • 负责人:
  • 金额:
    $ 49.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-14 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Changes in the levels of microRNAs and effects of over-expression of microRNAs have already been related to human malignancy. However, the mechanisms by which microRNAs control cellular states and how this control is altered under stress conditions and in stationary verses proliferating cells have not been investigated. We present preliminary data indicating that microRNA-mediated regulation is important during the cell's response to stress and propose to study this relationship in normal and malignant cells. Preliminary bioinformatic analysis suggests that many mRNAs that are targets of microRNA regulation also contain conserved sites for RNA binding proteins that are known to control translation and mRNA stability during stress. mRNAs targeted by both microRNAs and stress-related RNA binding proteins can be preferentially expressed during stress. We propose to characterize the differential binding of proteins to Argonaute/microRNA complexes under stress and non-stress conditions using Stable Isotope Labeling with Amino acids in Cell culture (SILAC). We present preliminary evidence detecting differences in bound proteins under these two conditions. These proteins will be analyzed for their roles in cellular processes such as translational regulation, subcellular targeting, and mRNA stability. We further propose to identify the total set of mRNAs targeted by microRNAs by selective immunoprecipitation of Argonaute bound mRNAs from Dicer- negative embryonic stem cells, thus deficient in endogenous microRNAs that have been transfected with a single microRNA. In total, these experiments should reveal the importance of microRNA- regulation during stress conditions and could identify drug targets that could be used to preferentially inhibit/kill tumor cells undergoing stress-associated tumorigenesis. Gene regulation by microRNAs could also change during tumorigenesis if the target sites in 3' UTRs disappear. We have discovered that a large number of genes is expressed with short 3' UTRs during proliferation and longer 3' UTRs in quiescent cells. This shift was observed when arrays were used to compare mRNA expression in resting CD4-T cells and receptor stimulated CD4 cells. Further bioinformatic analysis shows this shift occurs in most resting verses proliferating tissues and in tumor verses normal tissue. The long 3' UTRs in resting cells almost certainly mediate enhanced microRNA regulation because they contain conserved seed target sites. We proposed to continue this analysis by investigating the nature of the factors controlling the proliferation-dependent shift, the importance of this change in microRNA control of the malignant phenotype, and how this shift can be modulated to induce more microRNA regulation in cancer cells. PUBLIC HEALTH RELEVANCE: The burden of cancer in public health is apparent in both human suffering and the cost of healthcare. The proposed research will provide the basis for new therapeutics to better treat cancer and thus improve public health.
描述(由申请人提供):microRNA水平的变化和microRNA过表达的影响已经与人类恶性肿瘤相关。然而,microRNA控制细胞状态的机制以及这种控制在应激条件下以及在静止细胞与增殖细胞中如何改变尚未研究。我们目前的初步数据表明,microRNA介导的调节是重要的,在细胞的应激反应,并建议在正常和恶性细胞中研究这种关系。初步的生物信息学分析表明,许多作为microRNA调控靶点的mRNA也含有已知在应激期间控制翻译和mRNA稳定性的RNA结合蛋白的保守位点。microRNA和应激相关RNA结合蛋白靶向的mRNA在应激过程中可以优先表达。我们建议使用细胞培养中氨基酸稳定同位素标记(SILAC)来表征应激和非应激条件下蛋白质与Argonaute/microRNA复合物的差异结合。我们目前的初步证据检测在这两种条件下结合蛋白质的差异。这些蛋白质将分析其在细胞过程中的作用,如翻译调控,亚细胞靶向和mRNA稳定性。我们进一步提出通过选择性免疫沉淀来自Dicer阴性胚胎干细胞的Argonaute结合mRNA来鉴定由microRNA靶向的mRNA的总集合,因此缺乏已经用单个microRNA转染的内源性microRNA。总之,这些实验应该揭示应激条件下microRNA调节的重要性,并可以鉴定可用于优先抑制/杀死经历应激相关肿瘤发生的肿瘤细胞的药物靶标。如果3'UTR中的靶位点消失,microRNA的基因调控也可能在肿瘤发生过程中发生变化。我们已经发现,大量基因在增殖期间以短的3'UTR表达,而在静止细胞中以较长的3' UTR表达。当使用阵列比较静息CD 4-T细胞和受体刺激的CD 4细胞中的mRNA表达时,观察到这种变化。进一步的生物信息学分析表明,这种转变发生在大多数静息组织与增殖组织以及肿瘤与正常组织中。静息细胞中的长3'UTR几乎肯定介导增强的microRNA调节,因为它们含有保守的种子靶位点。我们建议通过研究控制增殖依赖性转变的因素的性质,这种变化在恶性表型的microRNA控制中的重要性,以及如何调节这种转变以诱导癌细胞中更多的microRNA调节来继续这种分析。公共卫生相关性:癌症在公共卫生中的负担在人类痛苦和医疗保健费用方面都很明显。这项拟议中的研究将为更好地治疗癌症的新疗法提供基础,从而改善公众健康。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Phillip A Sharp其他文献

Phillip A Sharp的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Phillip A Sharp', 18)}}的其他基金

Nanoformulations for siRNA Delivery to Ovarian Cancer
用于卵巢癌 siRNA 递送的纳米制剂
  • 批准号:
    7983674
  • 财政年份:
    2010
  • 资助金额:
    $ 49.5万
  • 项目类别:
Characterization of Pathways Controlling Cancer at the Level of Gene Regulation
基因调控水平控制癌症途径的表征
  • 批准号:
    7913508
  • 财政年份:
    2009
  • 资助金额:
    $ 49.5万
  • 项目类别:
TREATMENT OF CANCER WITH siRNA DELVIERED BY NANOPARTICLES
利用纳米颗粒提供的 siRNA 治疗癌症
  • 批准号:
    7738123
  • 财政年份:
    2008
  • 资助金额:
    $ 49.5万
  • 项目类别:
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
压力和增殖状态影响 MicroRNA 介导的癌症调节
  • 批准号:
    9036337
  • 财政年份:
    2008
  • 资助金额:
    $ 49.5万
  • 项目类别:
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
压力和增殖状态影响 MicroRNA 介导的癌症调节
  • 批准号:
    8686767
  • 财政年份:
    2008
  • 资助金额:
    $ 49.5万
  • 项目类别:
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
压力和增殖状态影响 MicroRNA 介导的癌症调节
  • 批准号:
    8826043
  • 财政年份:
    2008
  • 资助金额:
    $ 49.5万
  • 项目类别:
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
压力和增殖状态影响 MicroRNA 介导的癌症调节
  • 批准号:
    8501813
  • 财政年份:
    2008
  • 资助金额:
    $ 49.5万
  • 项目类别:
Stress and proliferation states impact microRNA-mediated regulation in cancer
应激和增殖状态影响 microRNA 介导的癌症调节
  • 批准号:
    8072151
  • 财政年份:
    2008
  • 资助金额:
    $ 49.5万
  • 项目类别:
Stress and proliferation states impact microRNA-mediated regulation in cancer
应激和增殖状态影响 microRNA 介导的癌症调节
  • 批准号:
    8265281
  • 财政年份:
    2008
  • 资助金额:
    $ 49.5万
  • 项目类别:
Stress and proliferation states impact microRNA-mediated regulation in cancer
应激和增殖状态影响 microRNA 介导的癌症调节
  • 批准号:
    7674684
  • 财政年份:
    2008
  • 资助金额:
    $ 49.5万
  • 项目类别:

相似国自然基金

帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
  • 批准号:
    31672538
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 批准年份:
    2013
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
  • 批准号:
    81172529
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
  • 批准号:
    81070952
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
  • 批准号:
    30672361
  • 批准年份:
    2006
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目

相似海外基金

How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
  • 批准号:
    DP240103141
  • 财政年份:
    2024
  • 资助金额:
    $ 49.5万
  • 项目类别:
    Discovery Projects
Structural classification of NHEJ pathways; unravelling the role of Ku-binding proteins
NHEJ通路的结构分类;
  • 批准号:
    MR/X00029X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
    Research Grant
BRC-BIO: Evolutionary Patterns of Ice-Binding Proteins in North Pacific Intertidal Invertebrates
BRC-BIO:北太平洋潮间带无脊椎动物冰结合蛋白的进化模式
  • 批准号:
    2312378
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
    Standard Grant
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
  • 批准号:
    23K06408
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
  • 批准号:
    10680969
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
  • 批准号:
    10744556
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
Structural and computational analysis of immune-related RNA-binding proteins
免疫相关 RNA 结合蛋白的结构和计算分析
  • 批准号:
    23K06597
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of carbohydrate-binding proteins and their applications
碳水化合物结合蛋白的表征及其应用
  • 批准号:
    23K05034
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A machine learning approach to identify carbon dioxide-binding proteins for sustainability and health
一种机器学习方法来识别二氧化碳结合蛋白以实现可持续发展和健康
  • 批准号:
    2838427
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
    Studentship
The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
  • 批准号:
    10827567
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了